Psychopharmacology Update: 2026
CLICK HERE to register
Free for MPS Members, $25 for Non-Members
Agenda:
7:00-7:15 Welcome
7:15-7:45 Rachel Talley, MD
7:45-8:15 Bernadette Wharton-Hawthorne, MD
8:15-8:45 Robert Hudak, MD
8:45-9:30 Question and Answer Session
Objectives:
At the conclusion of the activity participants will be able to:
- Understand the current evidence base for assisted outpatient treatment (AOT)
- Understand the state of Maryland’s implementation approach for AOT implementation, including the value of diverse stakeholder engagemen
- Understand early successes and challenges of Maryland’s AOT implementation
- Review the mechanism of action and current landscape of GLP-1s within the broader medical and psychiatric field
- Review current evidence for use of GLP-1s in eating disorders and discuss gaps in the literature
- Discuss assessing and mitigating risks for vulnerable populations who may be taking GLP-1s
- Define and discuss treatment resistant OCD
- Review the steps in medical management of treatment resistant patients
- Discuss the role of glutamatergic agents and the relevant research
Thank you to our supporters:
Accreditation and Designation Statement
In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and The Maryland Psychiatric Society (MPS) APA is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The APA designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Financial Disclosures
Planning Committee
Jora Hritz has no relevant financial relationships to disclose.
Joshua Chiappelli, M.D. has no relevant financial relationships to disclose.
Paul Nestadt, M.D. has no relevant financial relationships to disclose.
Faculty Disclosures
Robert Hudak, MD has no relevant financial relationships to disclose
Rachel Talley, MD
Bernadette Wharton-Hawthorne, MD has no relevant financial relationships to disclosure